AI assistant
Merck & Co., Inc. — Director's Dealing 2025
Aug 5, 2025
284_dirs_2025-08-05_1d9a21c1-804d-409d-9574-0e891bf33302.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-08-04
Reporting Person: Williams David Michael (EVP,Chief Info&Digital Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-04 | Common Stock | M | 17119 | $79.29 | Acquired | 41445.467 | Direct |
| 2025-08-04 | Common Stock | F | 8432 | $79.29 | Disposed | 33013.467 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-04 | Restricted Stock Unit | $ | M | 17119 | Disposed | 2025-08-03 | Common Stock (17119) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 8/4/2025, the business day immediately following 8/3/2025. The Reporting Person's Form 4 filed on 8/4/2022 incorrectly reported that these restricted stock units vested and were to be distributed in three equal installments on 8/3/2023, 8/3/2024, and 8/3/2025.